Skip to main content
Back
Watch Compare

Alzamend Neuro, Inc.

Data quality: 83%
ALZN
NASDAQ Manufacturing Chemicals
$0.86
▼ $0.04 (-4.93%)
Mkt Cap: 3.43 M
Price
$0.90
Mkt Cap
3.43 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -11.84 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-317.66%
Below sector avg (-53.53%)
ROIC-179.78%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current RatioN/A
Interest Coverage-424.23

Valuation

PE (TTM)
-0.33
Above sector avg (-1.48)
P/B Ratio1.57
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -0.3 -1.5
P/B 1.6 1.6
ROE % -317.7 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

1 analyst
Buy
Current
$0.86
+2813.8%
Target
$25.00
$25.00
$25.00
$25.00
Forecast
Forward P/E -0.33
Forward EPS -$2.60
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$2.60
-$2.60 – -$2.60
 0.0 1
FY2026 -$2.58
-$2.58 – -$2.58
 0.0 1

Earnings Surprises

Last 6 quarters
Quarter Est. EPS Actual EPS Surprise
Q12026 -$0.53 -$0.58 -9.4%
Q42025 -$1.96 -$0.30 +84.7%
Q32025 -$0.69 -$1.28 -85.5%
Q22025 -$2.70 -$9.48 -251.1%
2026-Q3 -$0.67 -$0.56 +16.4%
2026-Q2 -$0.67 -$0.05 +92.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -10.42 M
ROE -317.66% ROA -228.11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -11.84 M
ROIC -179.78% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage -424.23 Asset Turnover N/A
Working Capital N/A Tangible Book Value 2.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.33 Forward P/E N/A
P/B Ratio 1.57 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -344.77%
Market Cap 3.43 M Enterprise Value 720,639.0
Per Share
EPS (Diluted TTM) -13.21 Revenue / Share N/A
FCF / Share -3.11 OCF / Share -3.11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 113.64%
SBC-Adj. FCF -12.00 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -4.51 M -9.95 M -14.88 M -12.36 M -5.05 M
EPS (Diluted) -11.32 -14.70 -0.15 — —
Gross Profit — — — — —
Operating Income -4.50 M -9.94 M -14.87 M -12.32 M -4.95 M
EBITDA — — — — —
R&D Expenses 1.41 M 6.46 M 7.45 M 5.20 M 1.31 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 18,029.0 10,101.0 7,701.0 46,524.0 142,421.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 4.60 M 631,588.0 5.92 M 14.52 M 2.91 M
Total Liabilities 634,761.0 3.23 M 2.87 M 1.16 M —
Shareholders' Equity 3.97 M -2.59 M 3.05 M 13.35 M 2.01 M
Total Debt — — — — —
Cash & Equivalents 3.95 M 376,048.0 5.14 M 14.06 M 1.93 M
Current Assets 4.18 M 455,242.0 5.84 M 14.41 M 2.91 M
Current Liabilities — — 2.87 M 1.16 M 899,643.0